Combined therapeutic effects of gamma delta T cells and zoledronic acid on glioblastoma patients-derived organoids
Glioblastoma patients-derived organoids (GBOs) were treated with 2x10^5 gamma delta T cells, 5 uM zoledronic acid (ZA), or their combination